DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Quinn MA, Conaghan PG, O’Connor PJ. et al.
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Arthritis Rheum 2005; 52: 27-35
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.